Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of Outstanding Shares of Potentially Dilutive Securities were Excluded from the Computation of Diluted Net Income (Loss) Per Share

v3.23.2
Net Loss Per Share (Details) - Schedule of Outstanding Shares of Potentially Dilutive Securities were Excluded from the Computation of Diluted Net Income (Loss) Per Share - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Schedule of Outstanding Shares of Potentially Dilutive Securities were Excluded from the Computation of Diluted Net Loss Per Share [Abstract]        
Options to purchase common stock 1,334,309 1,177,104 1,334,309 1,177,104
Warrants to purchase common stock 4,784,193 4,784,193 4,784,193 4,784,193
Warrants to purchase convertible preferred stock 160,958,167 160,958,167
Total 167,076,669 5,961,297 167,076,669 5,961,297